|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance of $25.4 at June 30, 2025 and $25.8 at December 31, 2024 (Notes 3 and 13) | ||||||||||||||||||||
| Prepaid taxes | ||||||||||||||||||||
| Other prepaids | ||||||||||||||||||||
| Swap derivative assets (Note 13) | ||||||||||||||||||||
| Other current assets (Note 3 and 9) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $62.4 at June 30, 2025 and $54.6 at December 31, 2024 | ||||||||||||||||||||
| Computer software, net of accumulated amortization of $797.9 at June 30, 2025 and $666.3 at December 31, 2024 (Note 10) | ||||||||||||||||||||
| Goodwill (Notes 10 and 16) | ||||||||||||||||||||
| Deferred income tax | ||||||||||||||||||||
| Other intangibles (Notes 10 and 16) | ||||||||||||||||||||
| Deferred costs (Note 3) | ||||||||||||||||||||
| Other non-current assets (Note 11) | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Accrued income tax | ||||||||||||||||||||
| Short-term debt (Note 12) | ||||||||||||||||||||
| Deferred revenue (Note 3) | ||||||||||||||||||||
| Other accrued and current liabilities (Note 11) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term pension and postretirement benefits (Note 6) | ||||||||||||||||||||
| Long-term debt (Note 12) | ||||||||||||||||||||
| Liabilities for unrecognized tax benefits | ||||||||||||||||||||
| Deferred income tax | ||||||||||||||||||||
| Other non-current liabilities (Note 11) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common Stock, $0.0001 par value per share, authorized—2,000,000,000 shares; 448,171,624 shares issued and 446,323,238 shares outstanding at June 30, 2025 and 443,399,772 shares issued and 441,551,492 shares outstanding at December 31, 2024 | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury Stock, 1,848,386 shares at June 30, 2025 and 1,848,280 shares at December 31, 2024 | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Treasury stock (in shares) | ||||||||||||||||||||
Loading...
